Help your patients make an informed decision about prostate cancer screenings.

Delaware has the fifth-highest incidence rate for prostate cancer in the U.S.

Overall, prostate cancer is the second-leading cause of cancer deaths in men. It is a major health issue. There have been differing opinions on whether prostate cancer screenings should be recommended. The American Cancer Society and the Delaware Cancer Consortium recommend that men should make an informed decision — considering the risks and benefits of screening — to decide what’s best for them.

Baseline screening recommendations for prostate cancer:

  • Average risk – men 50 years and older
  • High risk – men 45 years and older; high-risk men include African Americans and men who have a first-degree relative diagnosed with prostate cancer at an early age. Early age defined as less than 65 years).
  • Higher risk – men 40 years and older – men who have more than one first-degree relative who has had prostate cancer at an early age (less than 65).

Discuss the potential risks of a screening with your patient:

  • There’s the potential for a false positive, which could lead to a biopsy that could cause fever, infection, bleeding problems, and pain.
  • A diagnosis of a slow-growing, non-life-threatening cancer could result in treatment that causes complications, such as urinary incontinence and erectile dysfunction.

If your patients are underinsured or don’t have insurance, they may qualify for Screening for Life if they:

  • Are age 18 to 64
  • Are age 65 and older, and do not qualify for Medicare
  • Meet the income guidelines of Screening for Life (income scale is based on a family’s size and can be obtained by calling Delaware 2-1-1, toll-free)

Click here for cancer screening and treatment programs your patients should know about that can help them pay for screenings if they’re uninsured or underinsured, get cancer treatment if they can’t afford it, or get help navigating through cancer services.

To Top